Grefixyl (Brinzolamide, Brimonidine Tartrate)

Grefixyl is indicated for the treatment of elevated intraocular pressure associated with specific eye disorders. It is commonly prescribed to help control pressure and reduce the risk of optic nerve damage.

• Primary open‑angle glaucoma management
• Ocular hypertension reduction
• Adjunct therapy when monotherapy is insufficient
• Use in patients who require combined carbonic anhydrase inhibition and alpha‑2 agonism
• Treatment in adults diagnosed with elevated intraocular pressure

Grefixyl may cause a range of ocular and systemic effects, some of which are more frequently reported than others.

Common

• Transient eye irritation or burning sensation after instillation
• Temporary blurred vision lasting a few minutes
• Mild conjunctival hyperemia (redness)
• Slight headache or eye discomfort
• Dry eye sensation or foreign body feeling

Serious

• Persistent or severe eye pain
• Sudden loss of vision
• Allergic reactions such as swelling of the eyelids or face
• Signs of systemic hypotension (dizziness, fainting)
• Severe ocular inflammation or infection

Before using Grefixyl, certain precautions should be considered to ensure safe and effective therapy.

• Assess patient history for sulfonamide allergy, as brinzolamide contains a sulfonamide moiety
• Monitor intraocular pressure regularly after initiation and dose adjustments
• Use with caution in patients with cardiovascular disease or low blood pressure
• Advise patients to avoid touching the tip of the dropper to any surface to prevent contamination
• Counsel pregnant or nursing women that safety data are limited and to discuss risks with a healthcare provider
• Review concomitant ocular medications for potential additive effects on eye irritation

Grefixyl can interact with other medications, influencing its efficacy or safety profile.

Avoid

• Systemic carbonic anhydrase inhibitors (e.g., acetazolamide) that may increase the risk of metabolic acidosis
• Non‑selective beta‑blockers used topically in the eye, which can further lower intraocular pressure excessively
• Medications that cause significant hypotension when combined with brimonidine (e.g., clonidine)

Use with caution

• Other topical ocular vasoconstrictors, which may increase the risk of ocular irritation
• Systemic antihypertensive agents, as additive blood pressure‑lowering effects are possible
• Drugs that may cause sulfonamide cross‑reactivity, such as certain diuretics or antibiotics